Compare Definium Therapeutics Inc. Common Shares (DFTX) vs Exelon Corporation Common Stock (EXC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs Exelon Corporation Common Stock — how do they compare? Definium Therapeutics Inc. Common Shares trades at $35.4 (market cap $4.59B), while Exelon Corporation Common Stock trades at $41.74 (market cap $42.99B). The key difference: Exelon Corporation Common Stock is far larger — about 9.4× Definium Therapeutics Inc. Common Shares's market cap, and Exelon Corporation Common Stock pays a 4.03% dividend while Definium Therapeutics Inc. Common Shares pays none. Which is the better fit depends on your goals.
| DFTX | EXC | |
|---|---|---|
Market Cap | $4.59B | $42.99B |
Volume | 2,103,937 | 7,570,408 |
Sector | Health | Utilities |
52-Week High | $48.45 | $50.29 |
52-Week Low | $10.68 | $40.20 |
Typical Hold Time | 0 Days | — |
Enterprise Value | $3.55B | $93.85B |
Dividend Yield | — | 4.03% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About Exelon Corporation Common Stock
Exelon is the parent company of six regulated electric and natural gas utilities. Its utilities include Atlantic City Electric, BGE, ComEd, Delmarva Power, PECO, and Pepco.
Read more on EXC →
